STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more

At AACR, there was talk of Chinese biotech's place in cancer research, oncology’s comms issue, and more.
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

At AACR, there was talk of Chinese biotech's place in cancer research, oncology’s comms issue, and more.
Source
Stat News
Opens original article in a new tab

Watch RFK Jr. testify live before the Senate's health care panel.

(MedPage Today) -- Suicide deaths among adolescents and young adults declined across the U.S. after the launch of the 988 Suicide and Crisis Lifeline in 2022, according to an observational study. From July 2022 through December 2024, 35,529 suicides...

(MedPage Today) -- These days, we're overwhelmed with data. Every chart on every patient is packed full of data -- some of it incredibly useful and important, some of it just a lot of noise, some of it just copy-and-pasted and brought forward...

(MedPage Today) -- Cemdisiran, an investigational small interfering RNA (siRNA) therapy targeting complement component 5 (C5), met both its primary and a key secondary endpoint in the phase III NIMBLE trial of generalized myasthenia gravis, whether...